BioSpace News Archive

Zealand Pharma to participate in the Jefferies London Healthcare Conference in November 2023

Zealand Pharma A/S, a biotechnology company focused on the discovery and development of innovative peptide-based medicines, announced that it will participate in a fireside chat at the Jefferies London Healthcare Conference.

November 7, 2023
·
1 min read
Kynexis Launched to Advance Precision Therapeutics for Brain Diseases

Kynexis, a biotechnology company focused on precision therapeutics for brain diseases, launched with €57 million in Series A financing led by Forbion, with participation from Ysios Capital and Sunstone Life Science Ventures.

November 7, 2023
·
4 min read
Business

Science 37 Reports Third Quarter 2023 Financial Results

Science 37 Holdings, Inc., the industry-leading Metasite™, reported its financial results for the quarter ended September 30, 2023.

November 7, 2023
·
18 min read
Business

IDEAYA Biosciences, Inc. Reports Third Quarter 2023 Financial Results and Provides Business Update

IDEAYA Biosciences, Inc., a precision medicine oncology company committed to the discovery and development of targeted therapeutics, provided a business update and announced financial results for the third quarter ended September 30, 2023.

November 7, 2023
·
29 min read
Business

Mallinckrodt plc (in Examinership) Reports Third Quarter 2023 Financial Results

Mallinckrodt plc, a global specialty pharmaceutical company, reported its financial results for the third quarter ended September 29, 2023.

November 7, 2023
·
40 min read
Business

SOPHiA GENETICS Reports Financial Results for the Third Quarter of Fiscal 2023 Record results on growth acceleration, significant improvement in operating loss and cash burn

SOPHiA GENETICS SA, a cloud-native software company and a leader in data-driven medicine, reported financial results for the third quarter ended September 30, 2023.

November 7, 2023
·
22 min read
Business

Agenus Reports Third Quarter 2023 Results

Agenus Inc., a leader in discovering and developing novel immunological agents to treat various cancers, announced results for the third quarter 2023.

November 7, 2023
·
10 min read
Drug Development

BioRay Announces First-Patient-In for Phase I Clinical Study of BRY812, a Novel LIV-1 Targeting Antibody Drug Conjugate

BioRay Pharmaceutical Co., Ltd. announced that the first patient has been dosed in the Phase I Clinical trial of BRY812, a third-generation antibody-drug conjugate targeting LIV-1 for the treatment of advanced malignant tumors.

November 7, 2023
·
2 min read
Business

Dewpoint Therapeutics Enters Strategic Partnership with Evotec to Accelerate Oncology Pipeline

Evotec SE and Dewpoint Therapeutics announced a strategic R&D collaboration to advance Dewpoint’s leading oncology pipeline programs of condensate modifying therapeutics to Investigational New Drug Applications using Evotec’s industry-leading fully integrated data-driven platform.

November 7, 2023
·
6 min read
RSNA 2023 spotlight: Sectra empowers improved work-life balance for radiologists

At this year’s Radiological Society of North America’s annual meeting, international medical imaging IT and cybersecurity company Sectra will showcase its latest developments to make workflows even more efficient, regardless of reading location.

November 7, 2023
·
4 min read